Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of subanesthetic dose esketamine on postoperative sleep in elderly patients after general anesthesia
ChiCTR2400084862Phase 4Not yet recruiting
- Sponsor
- Longchang People's Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Postoperative sleep disturbance (PSD), postoperative depression and postoperative pain (2 arms), sponsored by Longchang People's Hospital. Primary endpoint: Incidence of postoperative sleep disorders on postoperative day 1 and day 3. Planned start May 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Postoperative sleep disturbance (PSD)postoperative depressionpostoperative pain
Beyond the preview
Go deeper on ChiCTR2400084862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084862.